ROSUVASTATIN TEVA PHARMA
40MG TBL FLM 28 IV
| SÚKL code | 0244982 |
|---|---|
| Name of the product | ROSUVASTATIN TEVA PHARMA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ROSUVASTATIN TEVA PHARMA |
| Supplement | 40MG TBL FLM 28 IV |
| Strenght | 40MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 28 IV |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Tablet container |
| Legal status | na lékařský předpis |
| Active substance | ROSUVASTATIN CALCIUM (ROSUVASTATINUM CALCICUM) |
| ATC group | C10AA07 |
| ATC group name | ROSUVASTATIN |
Marketing authorisation information
| Registration Number | 31/ 551/15-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 12. 2021 |
| MA Holder | Teva Pharma B.V., Haarlem |
| MA Holder country | NIZOZEMSKO |
| Actual MA holder | Teva Pharma B.V., Haarlem |
| Actual MA holder country | NIZOZEMSKO |
cz